STRONGBRIDGE BIOPHARMA plc Accounts Receivable
STRONGBRIDGE BIOPHARMA plc had Accounts Receivable of $3.58 million as of 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2021-08-05
- 2021-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $3.58M.
- 2021-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $2.85M.
- 2020-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $2.80M.
- 2020-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $2.90M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2021-06-30 | $3.58M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.85M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $2.80M 10-Q · filed 2021-08-05 |
| 2020-09-30 | $2.90M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $2.88M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $2.69M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $2.29M 10-K · filed 2021-03-03 |
| 2019-09-30 | $3.36M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $6.34M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $3.92M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $1.63M 10-K · filed 2020-02-28 |
| 2018-09-30 | $2.54M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $2.38M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $2.02M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $1.58M 10-K · filed 2019-02-27 |
| 2017-09-30 | $979.00K 6-K · filed 2017-11-14 |
| 2017-06-30 | $616.00K 6-K · filed 2017-08-07 |